115 related articles for article (PubMed ID: 11216554)
1. Marked variation in peritoneal insulin absorption in peritoneal dialysis.
Fine A; Parry D; Ariano R; Dent W
Perit Dial Int; 2000; 20(6):652-5. PubMed ID: 11216554
[TBL] [Abstract][Full Text] [Related]
2. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
Pantsulaia T; Chokhonelidze I; Lomitashvili T
Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
[TBL] [Abstract][Full Text] [Related]
3. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of peritoneal transport between insulin-dependent and noninsulin-dependent and noninsulin-dependent diabetic peritoneal dialysis patients.
Lin JJ; Wadhwa NK; Suh H; Cabralda T
Perit Dial Int; 1997; 17(2):208-9. PubMed ID: 9159849
[No Abstract] [Full Text] [Related]
5. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
[No Abstract] [Full Text] [Related]
6. Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.
Bernardo AP; Oliveira JC; Santos O; Carvalho MJ; Cabrita A; Rodrigues A
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2205-12. PubMed ID: 26507143
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
[TBL] [Abstract][Full Text] [Related]
8. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal membrane transport for low molecular weight substances with the use of one bag dialysate collection.
Ikonomou M; Katopodis K; Nousia P; Tzalavra E; Koliousi E; Tsaliou B; Katsaraki A; Betsiou V; Dimitriou A; Theodorou J; Siamopoulos KC
EDTNA ERCA J; 1999; 25(2):22-3. PubMed ID: 10531877
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of transperitoneal insulin transport.
Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
[TBL] [Abstract][Full Text] [Related]
14. Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis.
Kathuria P; Moore HL; Khanna R; Twardowski ZJ; Goel S; Nolph KD
Perit Dial Int; 1997; 17(5):449-54. PubMed ID: 9358526
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport in type I (insulin-dependent) and type II (noninsulin-dependent) diabetic peritoneal dialysis patients.
Lin JJ; Wadhwa NK; Suh H; Cabralda T
Adv Perit Dial; 1995; 11():60-2. PubMed ID: 8534739
[TBL] [Abstract][Full Text] [Related]
16. Plasma insulin and glucose levels in diabetic patients undergoing continuous ambulatory peritoneal dialysis using insulin only in the dialysate.
Dolgos ET; Vidt DG; Schumacher OP; Gupta MK
Cleve Clin Q; 1984; 51(4):611-4. PubMed ID: 6395991
[No Abstract] [Full Text] [Related]
17. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
18. The minimal importance of the hollow viscera to peritoneal transport during peritoneal dialysis in the rat.
Rubin J; Jones Q; Planch A; Bower JD
ASAIO Trans; 1988; 34(4):912-5. PubMed ID: 3064790
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal transport of glucose in rat.
Park MS; Lee EY; Suh GI; Waniewski J; Werynski A; Lee HB
Perit Dial Int; 1999; 19(5):442-50. PubMed ID: 11379857
[TBL] [Abstract][Full Text] [Related]
20. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
